Aphria Inc. (NYSE: ACB) announced on October 30th that the company has received approval to list onto the New York Stock Exchange (NYSE) and that it will begin trading on November 2nd. The company had recently filed a form 40-F with the Securities Exchange Commission (SEC) to list onto the NYSE. Aphria’s stock symbol will not be APH due to the company Amphenol already trading on the NYSE and will instead trade under APHA. The company’s symbol on the Toronto Stock Exchange (TSX) will change to APHA with its debut on November 2nd.

The company will join a short list of cannabis industry producers that trade on public stock exchanges within the United States. Aurora Cannabis recently increased that short-list to 4 producers with active shares on a U.S. stock exchange on October 23rd of this year. It is expected that Alefia, CannTrust, and HEXO Corp are on their way to U.S. markets as the companies have either filed a Form 40-F with the Securities Exchange Commission (SEC) or they have announced its intent to do so.

Aphria’s Chief Executive Officer, Vic Neufeld, said, “Listing on the NYSE provides Aphria with access to the largest equity market in the world, with increased exposure to a vast array of U.S. institutional and retail investors”.